Emotional enhancement

Emotional enhancement is an intensification of felt emotional states — pleasant, unpleasant, or ambivalent — that arises acutely from psychoactive substance use.

As a drug effect it is dose-proportional and context-dependent, easing as the substance wears off, distinct from a standing mood disorder. It ranges from a subtle brightening of affect to an overwhelming amplification of emotion, with valence shaped as much by mindset and setting as by the compound.

Emotional enhancement is among the more commonly reported effects across psychoactive classes. It is most commonly induced at moderate to high doses under psychedelics such as LSD, psilocybin mushrooms, and DMT, and under stimulants such as MDMA and 6-APB; it also appears under cannabinoids such as JWH-018, and at low doses under depressants like alcohol and pregabalin, where emotional loosening is characteristic.

Emotional enhancement is felt as an amplification of whatever emotional tone is already present: feelings that ordinarily sit at the edges of awareness move to the foreground, acquiring weight and clarity.

It commonly comes with warmth in the chest, a loosening of social reserve, and heightened sensitivity to music, conversation, or memory. Attending to a feeling tends to deepen it.

At higher doses, particularly under psychedelics and stimulants such as MDMA, the amplification can become total — joy ecstatic, grief acute — with little middle ground.

Emotional enhancement arises through different pathways depending on the drug class:

• Psychedelics — act on 5-HT2A receptors, increasing cortical excitability and loosening habitual constraints on emotional processing.
• Stimulants — elevate monoamine activity; MDMA and 6-APB additionally promote release of prosocial neurochemistry, producing pronounced warmth and openness.
• Cannabinoids — act on CB1 receptors in limbic structures, modulating emotional salience in a dose- and context-sensitive way.
• Depressants — reduce inhibitory tone at low doses, releasing emotional expression before sedation predominates.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses consistently deepen the amplification. Set and setting exert strong influence — especially under psychedelics and cannabinoids — and people with prior experience or openness to introspection tend to encounter it most readily. Expecting emotional intensity tends to invite it.

Conversely, a guarded disposition, unfamiliar environments, and social tension can suppress or redirect the effect toward discomfort rather than enhancement.